These data indicated that autophagy is required for RRM2 to inhibit GBM cell proliferation through inducing G2/M phase cell cycle arrest by promoting CDK1 protein degradation, which supported by previous studies that p62-HDAC6 promoted CDK1 degradation through an autophagy-lysosome pathway in breast cancer (13). This evidence concerns the gene RRM2 and breast carcinoma.